Welcome to the CADTH Evidence Bundle for intravenous immunoglobulin (IVIG). Here you will find our best evidence on using IVIG – on label or off label – to treat different medical conditions.
Hot Topics
- Off-Label Use of Intravenous Immunoglobulin for Solid Organ Transplant Rejection: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Recurrent Spontaneous Abortion: A Review of Clinical Effectiveness (Summary with Critical Appraisal, May 2018)
- Off-Label Use of Intravenous Immunoglobulin for Dermatological Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Autoimmune or Inflammatory Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, April 2018)
- Off-Label Use of Intravenous Immunoglobulin for Hematological Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, March 2018)
- Off-Label Use of Intravenous Immunoglobulin for Neurological Conditions: A Review of Clinical Effectiveness (Summary with Critical Appraisal, March 2018)
- Off-Label Use of Intravenous Immunoglobulin: A Review of Clinical Effectiveness (Summary with Critical Appraisal, November 2017)
Browse the Evidence
Want to browse the evidence we have available on IVIG? Here you’ll find Summaries with Critical Appraisal, Summaries of Abstracts, and Health Technology Assessments on IVIG.